Journal Mobile Options
Table of Contents
Vol. 47, No. 4, 2012
Issue release date: April 2012
Ophthalmic Res 2012;47:195–201

Altered MicroRNA Expression Profiles in Retinas with Diabetic Retinopathy

Wu J. · Gao Y. · Ren A. · Zhao S. · Zhong M. · Peng Y. · Shen W. · Jing M. · Liu L.
Departments of Ophthalmology ataChanghai Hospital and bNo. 411 Hospital of CPLA, cDepartment of Pathophysiology, Second Military Medical University, Shanghai, China

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Rats with streptozotocin (STZ)-induced diabetes were studied in order to identify abnormal microRNA (miRNA) expression profiles in diabetic retinopathy (DR) and to ascertain miRNAs associated with DR. Histopathologically, we observed characteristic features of DR in rats at 10 weeks after STZ injection. Investigation of miRNA expression profiles in the retinas of control and diabetic rats using miRNA microarrays revealed that many miRNAs were abnormally expressed in DR. On the basis of their fold changes and probability values, a total of 37 miRNAs were selected for further validation by real-time PCR analysis. The results showed that 11 miRNAs were significantly upregulated and 6 miRNAs were notably downregulated in DR. Furthermore, these changes in retinal miRNA expression levels paralleled the course of DR. Levels of miR-182, miR-96, miR-183, miR-211, miR-204, and miR-124 were significantly increased during the progress of DR, whereas miR-10b, miR-10a, miR-219-2-3p, miR-144, miR-338, and miR-199a-3p were significantly decreased. Our data indicate that the aberrant miRNA expression profiles in DR are associated with the development of DR. Modulation of retinal miRNA expression levels may provide a potential therapeutic strategy for DRs.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.
  2. Plasterk RH: Micro RNAs in animal development. Cell 2006;124:877–881.
  3. Ambros V: The functions of animal microRNAs. Nature 2004;431:350–355.
  4. Ambros V: Micrornas: Tiny regulators with great potential. Cell 2001;107:823–826.
  5. Carrington JC, Ambros V: Role of microRNAs in plant and animal development. Science 2003;301:336–338.
  6. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401–1414.
  7. Pasquinelli AE, Ruvkun G: Control of developmental timing by microRNAs and their targets. Annu Rev Cell Dev Biol 2002;18:495–513.
  8. Makarev E, Spence JR, Del Rio-Tsonis K, Tsonis PA: Identification of microRNAs and other small rnas from the adult newt eye. Mol Vis 2006;12:1386–1391.
  9. Arora A, McKay GJ, Simpson DA: Prediction and verification of miRNA expression in human and rat retinas. Invest Ophthalmol Vis Sci 2007;48:3962–3967.
  10. Karali M, Peluso I, Marigo V, Banfi S: Identification and characterization of microRNAs expressed in the mouse eye. Invest Ophthalmol Vis Sci 2007;48:509–515.
  11. Ryan DG, Oliveira-Fernandes M, Lavker RM: MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis 2006;12:1175–1184.
  12. Damiani D, Alexander JJ, O’Rourke JR, McManus M, Jadhav AP, Cepko CL, Hauswirth WW, Harfe BD, Strettoi E: Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina. J Neurosci 2008;28:4878–4887.
  13. Loscher CJ, Hokamp K, Wilson JH, Li T, Humphries P, Farrar GJ, Palfi A: A common microRNA signature in mouse models of retinal degeneration. Exp Eye Res 2008;87:529–534.
  14. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA: MicroRNAs regulate ocular neovascularization. Mol Ther 2008;16:1208–1216.
  15. Cheung N, Mitchell P, Wong TY: Diabetic retinopathy. Lancet 376:124–136.
  16. Gargiulo P, Giusti C, Pietrobono D, La Torre D, Diacono D, Tamburrano G: Diabetes mellitus and retinopathy. Dig Liver Dis 2004;36(suppl 1):S101–S105.
  17. Cheung N, Wong TY: Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008;27:161–176.
  18. Mames RN: Diabetic retinopathy. Background, classification, pathophysiology. J Fla Med Assoc 1994;81:240–242.
  19. Lieth E, Gardner TW, Barber AJ, Antonetti DA: Retinal neurodegeneration: Early pathology in diabetes. Clin Experiment Ophthalmol 2000;28:3–8.
  20. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 1994;45:179–188.
  21. Martin A, Komada MR, Sane DC: Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003;23:117–145.
  22. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX: Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 2006;37:1–12.
  23. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M: Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002;134:348–353.
  24. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245–248.
  25. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676–1685.
  26. Gariano RF, Gardner TW: Retinal angiogenesis in development and disease. Nature 2005;438:960–966.
  27. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S: Microrna-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011;60:1314–1323.
  28. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RH: MicroRNA expression in zebrafish embryonic development. Science 2005;309:310–311.
  29. Jin ZB, Hirokawa G, Gui L, Takahashi R, Osakada F, Hiura Y, Takahashi M, Yasuhara O, Iwai N: Targeted deletion of mir-182, an abundant retinal microrna. Mol Vis 2009;15:523–533.
  30. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW: MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol 2007;8:R173.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50